Zepp Health (ZEPPN) Ratios
Zepp Health Ratios
MX:ZEPPN's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, MX:ZEPPN's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.02 | 1.29 | 2.04 | 1.77 | 1.83 |
| Quick Ratio | 0.77 | 1.00 | 1.49 | 1.16 | 1.24 |
| Cash Ratio | 0.39 | 0.57 | 0.91 | 0.58 | 0.70 |
| Solvency Ratio | -0.10 | -0.26 | -0.08 | -0.09 | 0.06 |
| Operating Cash Flow Ratio | -0.09 | -0.02 | 0.04 | -0.07 | -0.15 |
| Short-Term Operating Cash Flow Coverage | -0.15 | -0.03 | 0.08 | -0.12 | -0.60 |
| Net Current Asset Value | $ -397.03M | $ -177.37M | $ 240.61M | $ 370.44M | $ 777.98M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.40 | 0.34 | 0.31 | 0.33 | 0.22 |
| Debt-to-Equity Ratio | 1.06 | 0.72 | 0.56 | 0.65 | 0.46 |
| Debt-to-Capital Ratio | 0.52 | 0.42 | 0.36 | 0.39 | 0.32 |
| Long-Term Debt-to-Capital Ratio | 0.22 | 0.23 | 0.25 | 0.20 | 0.20 |
| Financial Leverage Ratio | 2.63 | 2.10 | 1.81 | 1.97 | 2.08 |
| Debt Service Coverage Ratio | -0.17 | -0.55 | -0.22 | -0.18 | 0.32 |
| Interest Coverage Ratio | -5.13 | -8.51 | -4.51 | -7.20 | 2.09 |
| Debt to Market Cap | 59.27 | 4.28 | 8.91 | 10.85 | 2.52 |
| Interest Debt Per Share | 1644.55 | 84.67 | 377.64 | 457.33 | 353.23 |
| Net Debt to EBITDA | -4.20 | -1.51 | -2.74 | -2.84 | -0.80 |
| Profitability Margins | |||||
| Gross Profit Margin | 39.20% | 38.46% | 26.17% | 19.39% | 20.89% |
| EBIT Margin | -12.30% | -28.67% | -7.90% | -7.62% | 2.42% |
| EBITDA Margin | -10.55% | -25.92% | -5.72% | -6.20% | 3.25% |
| Operating Profit Margin | -11.29% | -25.88% | -8.63% | -9.90% | 1.50% |
| Pretax Profit Margin | -14.50% | -34.02% | -9.50% | -8.57% | 2.36% |
| Net Profit Margin | -15.48% | -41.56% | -8.83% | -6.96% | 2.20% |
| Continuous Operations Profit Margin | -15.48% | -41.52% | -8.81% | -6.98% | 2.19% |
| Net Income Per EBT | 106.76% | 122.17% | 92.95% | 81.24% | 93.30% |
| EBT Per EBIT | 128.40% | 131.46% | 110.07% | 86.50% | 157.22% |
| Return on Assets (ROA) | -7.11% | -14.36% | -4.90% | -5.65% | 2.24% |
| Return on Equity (ROE) | -18.73% | -30.18% | -8.87% | -11.14% | 4.66% |
| Return on Capital Employed (ROCE) | -10.54% | -14.19% | -6.33% | -11.77% | 2.36% |
| Return on Invested Capital (ROIC) | -6.58% | -10.79% | -5.10% | -7.48% | 1.92% |
| Return on Tangible Assets | -7.42% | -14.83% | -5.05% | -5.86% | 2.31% |
| Earnings Yield | -1049.19% | -180.47% | -143.97% | -190.57% | 26.90% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.53 | 2.31 | 4.30 | 4.91 | 5.68 |
| Payables Turnover | 1.95 | 2.20 | 6.98 | 7.55 | 3.71 |
| Inventory Turnover | 2.17 | 1.98 | 3.07 | 3.37 | 3.89 |
| Fixed Asset Turnover | 34.07 | 17.64 | 22.39 | 25.74 | 25.49 |
| Asset Turnover | 0.46 | 0.35 | 0.55 | 0.81 | 1.01 |
| Working Capital Turnover Ratio | 7.95 | 1.71 | 2.07 | 2.77 | 3.24 |
| Cash Conversion Cycle | 84.92 | 176.67 | 151.62 | 134.31 | 59.80 |
| Days of Sales Outstanding | 103.45 | 158.12 | 84.86 | 74.27 | 64.29 |
| Days of Inventory Outstanding | 168.28 | 184.38 | 119.05 | 108.37 | 93.91 |
| Days of Payables Outstanding | 186.81 | 165.83 | 52.29 | 48.34 | 98.40 |
| Operating Cycle | 271.73 | 342.50 | 203.91 | 182.64 | 158.20 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -180.76 | -1.51 | 11.21 | -30.43 | -84.20 |
| Free Cash Flow Per Share | -186.28 | -1.60 | 10.77 | -30.82 | -95.74 |
| Dividend Paid and CapEx Coverage Ratio | -32.77 | -16.37 | 25.37 | -15.06 | -7.30 |
| Capital Expenditure Coverage Ratio | -32.77 | -16.37 | 25.37 | -79.45 | -7.30 |
| Operating Cash Flow Coverage Ratio | -0.11 | -0.02 | 0.03 | -0.07 | -0.25 |
| Operating Cash Flow to Sales Ratio | -0.10 | -0.02 | 0.02 | -0.03 | -0.05 |
| Free Cash Flow Yield | -691.45% | -8.43% | 26.72% | -77.03% | -74.61% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.10 | -0.56 | -0.69 | -0.52 | 3.72 |
| Price-to-Sales (P/S) Ratio | 0.01 | 0.23 | 0.06 | 0.04 | 0.08 |
| Price-to-Book (P/B) Ratio | 0.02 | 0.17 | 0.06 | 0.06 | 0.17 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.14 | -11.86 | 3.74 | -1.30 | -1.34 |
| Price-to-Operating Cash Flow Ratio | -0.15 | -12.59 | 3.59 | -1.31 | -1.52 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | -0.00 | 0.03 | 0.00 | -0.10 |
| Enterprise Value Multiple | -4.34 | -2.40 | -3.81 | -3.43 | 1.72 |
| Enterprise Value | 831.61M | 828.19M | 544.91M | 896.45M | 345.27M |
| EV to EBITDA | -4.34 | -2.40 | -3.81 | -3.43 | 1.72 |
| EV to Sales | 0.46 | 0.62 | 0.22 | 0.21 | 0.06 |
| EV to Free Cash Flow | -4.49 | -32.00 | 13.32 | -7.56 | -0.92 |
| EV to Operating Cash Flow | -4.63 | -33.95 | 12.79 | -7.65 | -1.04 |
| Tangible Book Value Per Share | 1346.23 | 106.48 | 621.52 | 639.20 | 693.78 |
| Shareholders’ Equity Per Share | 1509.40 | 113.49 | 654.30 | 684.53 | 740.31 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.07 | -0.22 | 0.07 | 0.19 | 0.07 |
| Revenue Per Share | 1826.34 | 82.41 | 657.41 | 1095.49 | 1565.74 |
| Net Income Per Share | -282.65 | -34.25 | -58.04 | -76.24 | 34.52 |
| Tax Burden | 1.07 | 1.22 | 0.93 | 0.81 | 0.93 |
| Interest Burden | 1.18 | 1.19 | 1.20 | 1.12 | 0.97 |
| Research & Development to Revenue | 0.18 | 0.25 | 0.15 | 0.12 | 0.08 |
| SG&A to Revenue | 0.32 | 0.39 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.64 | 0.32 | -1.37 | 2.70 | -2.44 |
Currency in USD
